Share Your Patient Group’s Views on Drug Treatment Information

In most countries, regulations ensure that pharmaceutical companies enclose detailed information about their treatments in the product pack.

However, the growth of digital health may possibly give pharma companies some scope to do more for patients by improving their drug-treatment information (within current country regulations).

For this reason, PatientView is conducting research on how pharmaceutical companies can improve their drug-treatment information.  They invite you and your organization to contribute your opinions to the research (the results of which will be published as a report in August/September 2019). All responses to the survey will be ANONYMOUS, unless you request otherwise.

To thank you for sharing your views with the survey, they will send you a link to the report upon publication (if you wish to receive it).



  • How patients feel treatment information should be improved (both before the treatment is prescribed, and when using the treatment).
  • How companies could address patients’ unmet needs for information.
  • How the industry can improve the minimum treatment information they supply, as defined by regulators (including through digital channels).


To be sure that your response to this survey is made in time, please complete the short questionnaire as soon as possible. (The survey closes end-July 2019). To take part, please click here.